Bacillus Calmette-Guérin induces cellular reactive oxygen species and lipid peroxidation in cancer cells

Urology

Volumn 79, Issue 6, 2012, Pages 1411.e15-1411.e20

  Rahmat, Juwita N ^a   Esuvaranathan, Kesavan ^a,b   Mahendran, Ratha ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BCG VACCINE; BETA1 INTEGRIN; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ARTICLE; BLADDER CANCER; CANCER CELL; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84861736699     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.01.017     Document Type: Article

References (30)

1. H.W. Herr, A. Morales History of Bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story J Urol 179 2008 53 56 (Pubitemid 350216725)
2. D.L. Lamm Efficacy and safety of Bacille Calmette-Guerin immunotherapy in superficial bladder cancer Clin Infect Dis 31 Suppl 3 2000 S86 S90
3. M.A. O'Donnell Optimizing BCG therapy Urol Oncol 27 2009 325 328
4. L.R. Kavoussi, E.J. Brown, J.K. Ritchey Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa Requirement for the expression of an antitumor response J Clin Invest 85 1990 62 67 (Pubitemid 20030291)
5. T.L. Ratliff, J.O. Palmer, J.A. McGarr Intravesical Bacillus Calmette-Guerin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guerin Cancer Res 47 1987 1762 1766 (Pubitemid 17056672)
6. K. Kuroda, E.J. Brown, W.B. Telle Characterization of the internalization of Bacillus Calmette-Guerin by human bladder tumor cells J Clin Invest 91 1993 69 76 (Pubitemid 23037254)
7. F. Chen, G. Zhang, Y. Iwamoto BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking BMC Urol 5 2005 1 8
8. S.H. Pook, J.N. Rahmat, K. Esuvaranathan Internalization of Mycobacterium bovis, Bacillus Calmette-Guerin, by bladder cancer cells is cytotoxic Oncol Rep 18 2007 1315 1320
9. S.H. Pook, K. Esuvaranathan, R. Mahendran N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized Mycobacterium bovis in human bladder cancer cells J Urol 168 2002 780 785 (Pubitemid 34793362)
10. P. Méndez-Samperio, A. Pérez, L. Torres Role of reactive oxygen species (ROS) in Mycobacterium bovis Bacillus Calmette-Guerin-mediated up-regulation of the human cathelicidin LL-37 in A549 cells Microb Pathog 47 2009 252 257
11. H. Akaza, A. Iwasaki, M. Ohtani Expression of antitumor response Role of attachment and viability of Bacillus Calmette-Guerin to bladder cancer cells Cancer 72 1993 558 563 (Pubitemid 23193467)
12. A. Siatelis, D.P. Houhoula, J. Papaparaskevas Detection of Bacillus Galmette-Guerin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma J Clin Microbiol 49 2011 1206 1208
13. E.C. de Boer, R.F. Bevers, K.H. Kurth Double fluorescent flow cytometric assessment of bacterial internalization and binding by epithelial cells Cytometry 25 1996 381 387 (Pubitemid 26418494)
14. J.A. Buege, S.D. Aust Microsomal lipid peroxidation Methods Enzymol 52 1978 302 310
15. M. Bajpayee, A. Dhawan, D. Parmar Gender-related differences in basal DNA damage in lymphocytes of a healthy Indian population using the alkaline Comet assay Mutat Res 520 2002 83 91 (Pubitemid 35247576)
16. A. Koul, A. Choidas, M. Treder Cloning and characterization of secretory tyrosine phosphatases of Mycobacterium tuberculosis J Bacteriol 182 2000 5425 5432
17. D.L. Piddington, F.C. Fang, T. Laessig Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst Infect Immun 69 2001 4980 4987 (Pubitemid 32674481)
18. M. Sirkar, S. Majumdar Lipoarabinomannan-induced cell signaling involves ceramide and mitogen-activated protein kinase Clin Diagn Lab Immunol 9 2002 1175 1182 (Pubitemid 35291043)
19. H.G. Wiker, M. Harboe The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis Microbiol Rev 56 1992 648 661
20. S.B. Sable, D. Goyal, I. Verma Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins Eur Respir J 29 2007 337 346 (Pubitemid 46231913)
21. W.L. Beatty, D.G. Russell Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages Infect Immun 68 2000 6997 7002 (Pubitemid 32463413)
22. H. Esterbauer, R.J. Schaur, H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 1991 81 128 (Pubitemid 121003917)
23. H.J. Forman Reactive oxygen species and alpha,beta-unsaturated aldehydes as second messengers in signal transduction Ann N Y Acad Sci 1203 2010 35 44
24. S. Thomas, J.E. Lowe, V. Hadjivassiliou Use of the Comet assay to investigate the role of superoxide in glutathione-induced DNA damage Biochem Biophys Res Commun 243 1998 241 245 (Pubitemid 28414221)
25. A. Wang, J.L. Robertson, S.D. Holladay Measurement of DNA damage in rat urinary bladder transitional cells: improved selective harvest of transitional cells and detailed Comet assay protocols Mutat Res 634 2007 51 59 (Pubitemid 350011154)
26. See WA, Zhang G, Chen F, et alWA, Zhang G, Chen F, et al. p21 expression by human urothelial carcinoma cells modulates the phenotypic response to BCG. Urol Oncol 2010;28:526533.
27. R. Carretero, T. Cabrera, H. Gil BCG immunotherapy of bladder cancer induces selection of HLA class I-deficient tumor cells Int J Cancer 129 2011 839 846
28. E. Chiong, A. Kesavan, R. Mahendran NRAMP1 and hGPX1 gene polymorphism and response to Bacillus Calmette-Guerin therapy for bladder cancer Eur Urol 59 2011 430 437
29. S.P. Lerner, C.M. Tangen, H. Sucharew Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer Urol Oncol 27 2009 155 159
30. E.C. de Boer, S.J. Rooyakkers, D.H. Schamhart BCG dose reduction by decreasing the instillation frequency: effects on local Th1/Th2 cytokine responses in a mouse model Eur Urol 48 2005 333 338 (Pubitemid 40957114)